Alisha Holtzhausen, Ph.D.
Affiliations: | 2013 | Molecular Cancer Biology | Duke University, Durham, NC |
Area:
Molecular Biology, Oncology, Cell BiologyGoogle:
"Alisha Holtzhausen"Parents
Sign in to add mentorGerard C. Blobe | grad student | 2013 | Duke | |
(Bone morphogenetic proteins signal through Smad1/5/8 to induce MET, Smad2 to specify the dorsoventral axis and Smad3 to facilitate invasion.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Plebanek MP, Xue Y, Nguyen YV, et al. (2023) A SREBF2-dependent gene program drives an immunotolerant dendritic cell population during cancer progression. Biorxiv : the Preprint Server For Biology |
Theivanthiran B, Yarla N, Haykal T, et al. (2022) Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti-PD-1 immunotherapy. Science Translational Medicine. 14: eabq7019 |
Theivanthiran B, Haykal T, Cao L, et al. (2021) Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling Axis. Cancers. 13 |
DeVito NC, Sturdivant M, Thievanthiran B, et al. (2021) Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy. Cell Reports. 35: 109071 |
Holtzhausen A, Harris W, Ubil E, et al. (2019) TAM Family Receptor kinase inhibition reverses MDSC-mediated suppression and augments anti-PD-1 therapy in melanoma. Cancer Immunology Research |
Zhao F, Evans KS, Xiao C, et al. (2018) Stromal Fibroblasts Mediate Anti-PD-1 Resistance via MMP-9 and Dictate TGF-β Inhibitor Sequencing in Melanoma. Cancer Immunology Research |
Porrello A, Leslie PL, Harrison EB, et al. (2018) Factor XIIIA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking. Nature Communications. 9: 1988 |
Ubil E, Caskey L, Holtzhausen A, et al. (2018) Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response. The Journal of Clinical Investigation |
Zhao F, Xiao C, Evans KS, et al. (2018) Paracrine Wnt5a-β-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization. Immunity. 48: 147-160.e7 |
Holtzhausen A, Zhao F, Evans K, et al. (2015) Melanoma-derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy. Cancer Immunology Research |